Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet ...
AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...
Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs.
Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...
It’s the dawn of a new age as Medicare enrollees will be able to save a lot of money on their prescription drugs. “For those ...
A key cost-saving provision of the Inflation Reduction Act (IRA) goes into effect in the new year, limiting annual ...
Top Medicare Part D drugs without price negotiations have seen a 98% increase in list prices since their launch. Read more ...
Going into the new year, seniors who take prescription drugs and receive Medicare benefits are likely to shell out less for ...
Seniors on Medicare Part D will never pay more than $2,000 out-of-pocket for prescription drugs annually, thanks to a ...
A provision of the Inflation Reduction Act will cap out-of-pocket costs for prescription drugs at $2,000 per year for people ...
Before I took office, people with Medicare who took expensive drugs could face a crushing burden, paying $10,000 a year or more in copays for the drugs they need to stay alive,” said a statement from ...